✦ LIBER ✦

Novel chemotherapy agents for colorectal cancer: Oral fluoropyrimidines, oxaliplatin, and raltitrexed

✍ Scribed by Melanie E. Royce; Paulo M. Hoff; Richard Padzur

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3061 POSTER Phase I/II study of novel or

✍ M. Tahara; Y. Yamada; A. Ohtsu; K. Shirao; Y. Shimada; Y. Sasaki; W. Yamamoto; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Systemic therapy for colorectal cancer:

✍ Bert H O’Neil 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 118 KB

A randomized phase II study to compare o

✍ Cristina Gravalos, Antonieta Salut, Carlos García-Girón, Rocío García-Carbonero, 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 294 KB

Differential toxicity biomarkers for iri

✍ Cortejoso, LucÃa; GarcÃa, MarÃa I.; GarcÃa-Alfonso, Pilar; GonzÃ¡lez-Haba, E 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 232 KB

Oxaliplatin plus raltitrexed and leucovo

✍ Catalano, G; Comella, P; Casaretti, R; Crucitta, E; De Vita, F; Palmeri, S; Aval 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Benefits and Drawbacks of the Use of Ora

✍ Jim Cassidy 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 871 KB